Clinical Trial Update: EarlySense Monitoring Device Evaluation on COPD, CHF and Pneumonia Patients

View source ↗

Summary

A clinical trial evaluating the EarlySense monitoring device in patients with COPD, congestive heart failure, and pneumonia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Heart Failure
• Pneumonia

Drugs mentioned

• EarlySense Monitoring Device

Snippet

Sponsor: EarlySense Ltd. | Conditions: COPD Patients | Status: WITHDRAWN